Source:http://linkedlifedata.com/resource/pubmed/id/15140122
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2004-5-13
|
pubmed:abstractText |
Patients with symptomatic idiopathic venous thromboembolism and apparently cancer-free have an approximate 10% incidence of subsequent cancer. Apparently cancer-free patients with acute idiopathic venous thromboembolism were randomized to either the strategy of extensive screening for occult cancer or to no further testing. Patients had a 2-year follow-up period. Of the 201 patients, 99 were allocated to the extensive screening group and 102 to the control group. In 13 (13.1%) patients, the extensive screening identified occult cancer. In the extensive screening group, a single (1.0%) malignancy became apparent during follow-up, whereas in the control group a total of 10 (9.8%) malignancies became symptomatic [relative risk, 9.7 (95% CI, 1.3-36.8; P < 0.01]. Overall, malignancies identified in the extensive screening group were at an earlier stage and the mean delay to diagnosis was reduced from 11.6 to 1.0 months (P < 0.001). Cancer-related mortality during the 2 years follow-up period occurred in two (2.0%) of the 99 patients of the extensive screening group vs. four (3.9%) of the 102 control patients [absolute difference, 1.9% (95% CI, -5.5-10.9)]. Although early detection of occult cancers may be associated with improved treatment possibilities, it is uncertain whether this improves the prognosis.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1538-7933
|
pubmed:author |
pubmed-author:AmbrosioG BGB,
pubmed-author:CigoliniMM,
pubmed-author:FalangaAA,
pubmed-author:GirolamiAA,
pubmed-author:IeranMM,
pubmed-author:LensingA W AAW,
pubmed-author:MonrealMM,
pubmed-author:PiccioliAA,
pubmed-author:PrandoniPP,
pubmed-author:PrinsM HMH,
pubmed-author:SOMIT Investigators Group,
pubmed-author:ScannapiecoG LGL
|
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
884-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15140122-Adult,
pubmed-meshheading:15140122-Aged,
pubmed-meshheading:15140122-Aged, 80 and over,
pubmed-meshheading:15140122-Early Diagnosis,
pubmed-meshheading:15140122-Female,
pubmed-meshheading:15140122-Follow-Up Studies,
pubmed-meshheading:15140122-Humans,
pubmed-meshheading:15140122-Male,
pubmed-meshheading:15140122-Mass Screening,
pubmed-meshheading:15140122-Middle Aged,
pubmed-meshheading:15140122-Neoplasms,
pubmed-meshheading:15140122-Prognosis,
pubmed-meshheading:15140122-Thromboembolism,
pubmed-meshheading:15140122-Treatment Outcome,
pubmed-meshheading:15140122-Venous Thrombosis
|
pubmed:year |
2004
|
pubmed:articleTitle |
Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial.
|
pubmed:affiliation |
Department of Medical and Surgical Sciences, Second Division of Internal Medicine, University of Padua, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|